Artificial microRNA interference targeting AT1a receptors in paraventricular nucleus attenuates hypertension in rats
Open Access
- 29 September 2011
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 19 (8), 810-817
- https://doi.org/10.1038/gt.2011.145
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Therapeutic strategies for targeting excessive central sympathetic activation in human hypertensionExperimental Physiology, 2010
- Sympathetic Nervous System Modulation of Inflammation and Remodeling in the Hypertensive HeartHypertension, 2010
- Sympathoexcitation by Oxidative Stress in the Brain Mediates Arterial Pressure Elevation in Obesity-Induced HypertensionCirculation, 2009
- Specific Gene Silencing by Artificial MicroRNAs in Physcomitrella patens: An Alternative to Targeted Gene KnockoutsPlant Physiology, 2008
- Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAiProceedings of the National Academy of Sciences, 2008
- Glutamatergic Inputs in the Hypothalamic Paraventricular Nucleus Maintain Sympathetic Vasomotor Tone in HypertensionHypertension, 2007
- Selective Silencing of Angiotensin Receptor Subtype 1a (AT 1a R) by RNA InterferenceHypertension, 2005
- Vascular Remodeling in HypertensionHypertension, 2001
- Effects of arterial vasodilators on cardiac hypertrophy and sympathetic activity in rats.Hypertension, 1988
- Evaluation of medial hypertrophy in resistance vessels of spontaneously hypertensive rats.Hypertension, 1988